OraSure Technologies
Bethlehem · Founded 1987
About OraSure Technologies
OraSure Technologies develops, manufactures, and distributes oral fluid diagnostic and collection devices, and other technologies designed to detect or diagnose critical medical conditions. It offers its products to clinical laboratories, hospitals, clinics, community-based organizations, and other public health organizations as well as research and academic institutions, distributors, government agencies, physicians’ offices, and commercial and industrial entities. The company offers include point-of-care diagnostic products, oral fluid specimen collection devices that leverage proprietary oral fluid technologies, laboratory diagnostic products such as immunoassays and other in vitro diagnostic tests, and other medical devices. Its line of products include tests for the detection of antibodies to the HIV virus, including the OraQuick In-Home HIV Test, OraQuick ADVANCE Rapid HIV-1/2 Antibody Test, and the OraSure HIV-1 Oral Specimen Collection Device; a test for antibodies to the HCV virus, the OraQuick HCV Rapid Antibody Test; and oral fluid testing solutions for drugs of abuse testing, including Intercept Oral Fluid Drug Testing System and Q.E.D. Saliva Alcohol Test. OraSure also manufactures and sells several cryosurgical products. Histofreezer is a product for the cryosurgical removal of common and plantar warts and several other benign skin lesions, sold to the professional or physician office market, as well as an over-the-counter product for the cryosurgical removal of common and plantar warts. In addition, through its wholly-owned subsidiary, DNA Genotek Inc., the company provides oral fluid sample collection, stabilization, and preparation products for molecular diagnostic applications. Its over-the-counter products are available in pharmacies across North America, South America, Europe, and Australia. OraSure Technologies was founded in 1987 and is based in Bethlehem, Pennsylvania.
Company Facts
- Founded: 1987
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $100K – $500K
- Total funding: $136.0M
- Funding stage: IPO
- Last round: Grant (Sep 2022)
- Ticker: nasdaq:OSUR
- Website: orasure.com
- Phone: +1 (800) 869-3538
Industries & Categories
Biotechnology, Health Care, Industrial, Medical
Social Profiles
Canonical: https://fsome.com/organization/orasure-technologies-36834 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.